These Analysts Increase Their Forecasts On Danaher Following Upbeat Q3 Earnings

Benzinga

Oct 23

Danaher Corporation (NYSE:DHR) reported better-than-expected third-quarter financial results on Tuesday.

Danaher announced third-quarter adjusted earnings of $1.89 per share, which beat the analyst consensus estimate of $1.72 per share by 9.82%. For comparison, the company reported earnings of 1.71 per share in the same quarter last year.

Danaher reported $6.05 billion in quarterly revenue, beating analyst expectations of $6.01 billion.

"We are encouraged by our third quarter results," said Rainer Blair, president and CEO. "DBS-driven execution paired with continued momentum in our bioprocessing business and better-than-anticipated respiratory revenue at Cepheid enabled us to exceed our revenue, earnings and cash flow expectations."

Looking forward, the company maintained its full-year 2025 adjusted earnings guidance of $7.70 to $7.80 per share, versus estimates of $7.78 per share. Danaher also expects core revenue growth to land in the low-single digits for full-year 2025.

Danaher shares fell 0.4% to trade at $219.87 on Wednesday.

These analysts made changes to their price targets on Danaher following earnings announcement.

Barclays analyst Luke Sergott maintained Danaher with an Overweight rating and raised the price target from $225 to $250.
TD Cowen analyst Dan Brennan maintained the stock with a Buy and raised the price target from $250 to $260.

Considering buying DHR stock? Here’s what analysts think:

Read This Next:

Top 2 Materials Stocks That Are Ticking Portfolio Bombs

Photo via Shutterstock

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2577039292"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2577039292\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2577039292?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-23 01:01","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2577039292","market":"hk","top_or_hot":-1,"title":"These Analysts Increase Their Forecasts On Danaher Following Upbeat Q3 Earnings","media":"Benzinga","content":"<html><body><p><strong>Danaher Corporation</strong> (NYSE:DHR) reported better-than-expected third-quarter financial results on Tuesday.</p>\n<p>Danaher announced third-quarter adjusted earnings of $1.89 per share, which beat the analyst consensus estimate of $1.72 per share by 9.82%. For comparison, the company reported earnings of 1.71 per share in the same quarter last year.</p>\n<p>Danaher reported $6.05 billion in quarterly revenue, beating analyst expectations of $6.01 billion.</p>\n<p>\"We are encouraged by our third quarter results,\" said Rainer Blair, president and CEO. \"DBS-driven execution paired with continued momentum in our bioprocessing business and better-than-anticipated respiratory revenue at Cepheid enabled us to exceed our revenue, earnings and cash flow expectations.\"</p>\n<p>Looking forward, the company maintained its full-year 2025 adjusted earnings guidance of $7.70 to $7.80 per share, versus estimates of $7.78 per share. Danaher also expects core revenue growth to land in the low-single digits for full-year 2025.</p>\n<p>Danaher shares fell 0.4% to trade at $219.87 on Wednesday.</p>\n<p>These analysts made changes to their price targets on Danaher following earnings announcement.</p>\n<ul>\n<li>Barclays analyst Luke Sergott maintained Danaher with an Overweight rating and raised the price target from $225 to $250.</li>\n<li>TD Cowen analyst Dan Brennan maintained the stock with a Buy and raised the price target from $250 to $260.</li>\n</ul>\n<p><strong>Considering buying DHR stock? Here’s what analysts think:</strong> </p>\n<figure><img decoding=\"async\" height=\"506\" loading=\"lazy\" sizes=\"(max-width: 1024px) 100vw, 1024px\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2025/10/22125951/image-564-1024x506.png\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2025/10/22125951/image-564-1024x506.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/10/22125951/image-564-300x148.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/10/22125951/image-564-768x380.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/10/22125951/image-564.png 1088w\" width=\"1024\"/></figure>\n<p><strong>Read This Next: </strong></p>\n<ul>\n<li><strong>Top 2 Materials Stocks That Are Ticking Portfolio Bombs</strong></li>\n</ul>\n<p>Photo via Shutterstock</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These Analysts Increase Their Forecasts On Danaher Following Upbeat Q3 Earnings</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese Analysts Increase Their Forecasts On Danaher Following Upbeat Q3 Earnings\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2025-10-23 01:01</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p><strong>Danaher Corporation</strong> (NYSE:DHR) reported better-than-expected third-quarter financial results on Tuesday.</p>\n<p>Danaher announced third-quarter adjusted earnings of $1.89 per share, which beat the analyst consensus estimate of $1.72 per share by 9.82%. For comparison, the company reported earnings of 1.71 per share in the same quarter last year.</p>\n<p>Danaher reported $6.05 billion in quarterly revenue, beating analyst expectations of $6.01 billion.</p>\n<p>\"We are encouraged by our third quarter results,\" said Rainer Blair, president and CEO. \"DBS-driven execution paired with continued momentum in our bioprocessing business and better-than-anticipated respiratory revenue at Cepheid enabled us to exceed our revenue, earnings and cash flow expectations.\"</p>\n<p>Looking forward, the company maintained its full-year 2025 adjusted earnings guidance of $7.70 to $7.80 per share, versus estimates of $7.78 per share. Danaher also expects core revenue growth to land in the low-single digits for full-year 2025.</p>\n<p>Danaher shares fell 0.4% to trade at $219.87 on Wednesday.</p>\n<p>These analysts made changes to their price targets on Danaher following earnings announcement.</p>\n<ul>\n<li>Barclays analyst Luke Sergott maintained Danaher with an Overweight rating and raised the price target from $225 to $250.</li>\n<li>TD Cowen analyst Dan Brennan maintained the stock with a Buy and raised the price target from $250 to $260.</li>\n</ul>\n<p><strong>Considering buying DHR stock? Here’s what analysts think:</strong> </p>\n<figure><img decoding=\"async\" height=\"506\" loading=\"lazy\" sizes=\"(max-width: 1024px) 100vw, 1024px\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2025/10/22125951/image-564-1024x506.png\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2025/10/22125951/image-564-1024x506.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/10/22125951/image-564-300x148.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/10/22125951/image-564-768x380.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/10/22125951/image-564.png 1088w\" width=\"1024\"/></figure>\n<p><strong>Read This Next: </strong></p>\n<ul>\n<li><strong>Top 2 Materials Stocks That Are Ticking Portfolio Bombs</strong></li>\n</ul>\n<p>Photo via Shutterstock</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"DHR","symbol_name":"丹纳赫","start_time":0,"source_url":"https://www.benzinga.com/analyst-stock-ratings/price-target/25/10/48360785/these-analysts-increase-their-forecasts-on-danaher-following-upbeat-q3-earnings","article_id":"2577039292","we_media_id":"1052270027","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2577039292","pubTimestamp":1761152484,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Benzinga","introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"summary":" ","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"DHR":"丹纳赫"},"translate_title":"在第三季度盈利乐观后，这些分析师上调了对丹纳赫的预测","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DHR":1.5},"content_text":"Danaher Corporation (NYSE:DHR) reported better-than-expected third-quarter financial results on Tuesday.\nDanaher announced third-quarter adjusted earnings of $1.89 per share, which beat the analyst consensus estimate of $1.72 per share by 9.82%. For comparison, the company reported earnings of 1.71 per share in the same quarter last year.\nDanaher reported $6.05 billion in quarterly revenue, beating analyst expectations of $6.01 billion.\n\"We are encouraged by our third quarter results,\" said Rainer Blair, president and CEO. \"DBS-driven execution paired with continued momentum in our bioprocessing business and better-than-anticipated respiratory revenue at Cepheid enabled us to exceed our revenue, earnings and cash flow expectations.\"\nLooking forward, the company maintained its full-year 2025 adjusted earnings guidance of $7.70 to $7.80 per share, versus estimates of $7.78 per share. Danaher also expects core revenue growth to land in the low-single digits for full-year 2025.\nDanaher shares fell 0.4% to trade at $219.87 on Wednesday.\nThese analysts made changes to their price targets on Danaher following earnings announcement.\n\nBarclays analyst Luke Sergott maintained Danaher with an Overweight rating and raised the price target from $225 to $250.\nTD Cowen analyst Dan Brennan maintained the stock with a Buy and raised the price target from $250 to $260.\n\nConsidering buying DHR stock? Here’s what analysts think: \n\nRead This Next: \n\nTop 2 Materials Stocks That Are Ticking Portfolio Bombs\n\nPhoto via Shutterstock","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport,express","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}